Filanesib (ARRY-520)
Revision as of 22:33, 7 December 2019 by Warner-admin (talk | contribs) (Text replacement - "Category:Chemotherapeutic" to "")
Mechanism of action
From the NCI Drug Dictionary: A synthetic, small molecule targeting the kinesin spindle protein (KSP) with potential antineoplastic activity. KSP inhibitor ARRY-520 specifically inhibits KSP (kinesin-5 or Eg5), resulting in activation of the spindle assembly checkpoint, induction of cell cycle arrest during the mitotic phase, and consequently cell death in tumor cells that are actively dividing.